Disruption of Francisella tularensis Schu S4 iglI, iglJ, and pdpC Genes Results in attenuation for growth in human macrophages and in vivo virulence in mice and reveals a unique phenotype for pdpC

Infection and Immunity

Volumn 81, Issue 3, 2013, Pages 850-861

  Long, Matthew E ^a   Lindemann, Stephen R ^a,b,d   Rasmussen, Jed A ^b   Jones, Bradley D ^b   Allena, Lee Ann H ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; INTRACELLULAR GROWTH LOCUS PROTEIN I; INTRACELLULAR GROWTH LOCUS PROTEIN J; PATHOGENICITY DETERMINANT PROTEIN C; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; FEMALE; FRANCISELLA TULARENSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENICITY ISLAND; PHAGOLYSOSOME; PHAGOSOME; PRIORITY JOURNAL;

ANIMALS; BACTERIAL PROTEINS; FEMALE; FRANCISELLA TULARENSIS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MACROPHAGES; MICE; MICE, INBRED BALB C; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TULAREMIA; VIRULENCE;

EID: 84874716786     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00822-12     Document Type: Article

References (47)

1. McLendon MK, Apicella MA, Allen L-AH. 2006. Francisella tularensis: taxonomy, genetics, and immunopathogenesis of a potential agent of biowarfare. Annu. Rev. Microbiol. 60:167-185.
2. Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S. 1961. Tula- remia vaccine study. II. Respiratory challenge. Arch. Intern. Med. 107: 702-714.
3. Ellis J, Oyston PC, Green M, Titball RW. 2002. Tularemia. Clin. Microbiol. Rev. 15:631-646.
4. Sjostedt A. 2007. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann. N. Y. Acad. Sci. 1105:1-29.
5. Schulert GS, Allen L-AH. 2006. Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor. J. Leukoc. Biol. 80:563-571.
6. Clemens DL, Lee BY, Horwitz MA. 2005. Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect. Immun. 73:5892-5902.
7. Pierini LM. 2006. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors. Cell. Microbiol. 8:1361-1370.
8. Balagopal AA,. MacFarlane S, Mohapatra N, Soni S, Gunn JS, Schlesinger LS. 2006. Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect. Immun. 74:5114-5125.
9. Barel M, Hovanessian AG, Meibom K, Briand JP, Dupuis M, Charbit A. 2008. A novel receptor-ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu. BMC MIcrobiol. 8:145.
10. Schwartz JT, Barker JH, Long ME, Kaufman J, McCracken J, Allen L-AH. 2012. Natural IgM mediates complement-dependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum. J. Immunol. 189:3064-3077.
11. Clemens DL, Lee BY, Horwitz MA. 2004. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect. Immun. 72:3204-3217.
12. Golovliov I, Baranov V, Krocova Z, Kovarova H, Sjostedt A. 2003. An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect. Immun. 71:5940-5950.
13. Santic M, Molmeret M, Klose KE, Jones S, Abu Kwaik Y. 2005. The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm. Cell. Microbiol. 7:969-979.
14. Chong A, Wehrly TD, Nair V, Fischer ER, Barker JR, Klose KE, Celli J. 2008. The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression. Infect. Immun. 76:5488-5499.
15. Broms JE, Sjostedt A, Lavander M. 2010. The role of the Francisella tularensis pathogenicity island in type VI secretion, intracellular survival, and modulation of host cell signaling. Front. Microbiol. 1:136.
16. Nano FE, Zhang N, Cowley SC, Klose KE, Cheung KK, Roberts MJ, Ludu JS, Letendre GW, Meierovics AI, Stephens G, Elkins KL. 2004. A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 186:6430-6436.
17. Barker JR, Chong A, Wehrly TD, Yu JJ, Rodriguez SA, Liu J, Celli J, Arulanandam BP, Klose KE. 2009. The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Mol. Microbiol. 74:1459-1470.
18. Brotcke A, Weiss DS, Kim CC, Chain P, Malfatti S, Garcia E, Monack DM. 2006. Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis. Infect. Immun. 74:6642-6655.
19. Schmerk CL, Duplantis BN, Howard PL, Nano FE. 2009. A Francisella novicida pdpA mutant exhibits limited intracellular replication and remains associated with the lysosomal marker LAMP-1. Microbiology 155: 1498-1504.
20. Twine S, Bystrom M, Chen W, Forsman M, Golovliov I, Johansson A, Kelly J, Lindgren H, Svensson K, Zingmark C, Conlan W, Sjostedt A. 2005. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect. Immun. 73:8345-8352.
21. Buchan BW, McCaffrey RL, Lindemann SR, Allen L-AH, Jones BD. 2009. Identification of migR, a regulatory element of the Francisella tularensis live vaccine strain iglABCD virulence operon required for normal replication and trafficking in macrophages. Infect. Immun. 77:2517-2529.
22. Kadzhaev K, Zingmark C, Golovliov I, Bolanowski M, Shen H, Conlan W, Sjostedt A. 2009. Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model. PLoS One 4:e5463. doi:10.1371/journal.pone.0005463.
23. de Bruin OM, Duplantis BN, Ludu JS, Hare RF, Nix EB, Schmerk CL, Robb CS, Boraston AB, Hueffer K, Nano FE. 2011. The biochemical properties of the Francisella pathogenicity island (FPI)-encoded proteins, IglA, IglB, IglC, PdpB and DotU, suggest roles in type VI secretion. Microbiology 157:3483-3491.
24. Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, Monack DM. 2007. In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl. Acad. Sci. U. S. A. 104:6037-6042.
25. Ahlund MK, Ryden P, Sjostedt A, Stoven S. 2010. Directed screen of Francisella novicida virulence determinants using Drosophila melanogaster. Infect. Immun. 78:3118-3128.
26. Broms JE, Lavander M, Meyer L, Sjostedt A. 2011. IglG and IglI of the Francisella pathogenicity island are important virulence determinants of Francisella tularensis LVS. Infect. Immun. 79:3683-3696.
27. McCaffrey RL, Schwartz JT, Lindemann SR, Moreland JG, Buchan BW, Jones BD, Allen L-AH. 2010. Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis. J. Leukoc. Biol. 88:791-805.
28. Read A, Vogl SJ, Hueffer K, Gallagher LA, Happ GM. 2008. Francisella genes required for replication in mosquito cells. J. Med. Entomol. 45: 1108-1116.
29. Moule MG, Monack DM, Schneider DS. 2010. Reciprocal analysis of Francisella novicida infections of a Drosophila melanogaster model reveal host-pathogen conflicts mediated by reactive oxygen and imd-regulated innate immune response. PLoS Pathog. 6:e1001065. doi:10.1371/journal.ppat.1001065.
30. Lindemann SR, Peng K, Long ME, Hunt JR, Apicella MA, Monack DM, Allen L-AH, Jones BD. 2011. Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages. Infect. Immun. 79:581-594.
31. Horwitz MA, Silverstein SC. 1980. Legionnaires' disease bacterium (Legionella pneumophila) multiplies intracellularly in human monocytes. J. Clin. Invest. 66:441-450.
32. Rodriguez SA, Davis G, Klose KE. 2009. Targeted gene disruption in Francisella tularensis by group II introns. Methods 49:270-274.
33. Rodriguez SA, Yu JJ, Davis G, Arulanandam BP, Klose KE. 2008. Targeted inactivation of Francisella tularensis genes by group II introns. Appl. Environ. Microbiol. 74:2619-2626.
34. Schwartz JT, Allen L-AH. 2006. Role of urease in megasome formation and Helicobacter pylori survival in macrophages. J. Leukoc. Biol. 79:1214-1225.
35. Checroun C, Wehrly TD, Fischer ER, Hayes SF, Celli J. 2006. Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc. Natl. Acad. Sci. U. S. A. 103:14578-14583.
36. Wehrly TD, Chong A, Virtaneva K, Sturdevant DE, Child R, Edwards JA, Brouwer D, Nair V, Fischer ER, Wicke L, Curda AJ, Kupko JJ, III, Martens C, Crane DD, Bosio CM, Porcella SF, Celli J. 2009. Intracellular biology and virulence determinants of Francisella tularensis revealed by transcriptional profiling inside macrophages. Cell Microbiol. 11:1128-1150.
37. Geier H, Celli J. 2011. Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis. Infect. Immun. 79: 2204-2214.
38. Schulert GS, McCaffrey RL, Buchan BW, Lindemann SR, Hollenback C, Jones BD, Allen L-AH. 2009. Francisella tularensis genes required for inhibition of the neutrophil respiratory burst and intramacrophage growth identified by random transposon mutagenesis of strain LVS. Infect. Immun. 77:1324-1336.
39. Child R, Wehrly TD, Rockx-Brouwer D, Dorward DW, Celli J. 2010. Acid phosphatases do not contribute to the pathogenesis of type A Francisella tularensis. Infect. Immun. 78:59-67.
40. Bonquist L, Lindgren H, Golovliov I, Guina T, Sjostedt A. 2008. MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages. Infect. Immun. 76:3502-3510.
41. Nano FE, Schmerk C. 2007. The Francisella pathogenicity island. Ann. N. Y. Acad. Sci. 1105:122-137.
42. Barker JR, Klose KE. 2007. Molecular and genetic basis of pathogenesis in Francisella tularensis. Ann. N. Y. Acad. Sci. 1105:138-159.
43. Lyons CR, Wu TH. 2007. Animal models of Francisella tularensis infection. Ann. N. Y. Acad. Sci. 1105:238-265.
44. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969.
45. Gavrilin MA, Wewers MD. 2011. Francisella recognition by inflammasomes: differences between mice and men. Front. Microbiol. 2:11.
46. Sjodin A, Svensson K, Lindgren M, Forsman M, Larsson P. 2010. Whole-genome sequencing reveals distinct mutational patterns in closely related laboratory and naturally propagated Francisella tularensis strains. PLoS One 5:e11556. doi:10.1371/journal.pone.0011556.
47. Barry EM, Cole LE, Santiago AE. 2009. Vaccines against tularemia. Hum. Vaccin. 5:832-838.